Skip to main content
SpringerLink
Log in

Antimikrobielle Chemotherapeutika

  • Chapter
Wirkstoffe in der dermatologischen Therapie

  • 69 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Rasmussen JE (1981) The problem of lindane. J Am Acad Dermatol 5: 507–516

    Article  PubMed  CAS  Google Scholar 

  2. Maibach HI, Khan AA (1983) Topical insect repellents: Volatility modifications. In: Frost P, Gomez EC, Zaias N (eds). Recent advances in dermatopharmacology. Spectrum Publ, New York, pp 243–250

    Google Scholar 

  3. Lutz U, Jaspersen HP (1982) Repellentien und Insektenabwehr. Dtsch Apoth Ztg 122: 1539–1543

    Google Scholar 

  4. Wagner WH, Düwel D (1980) Parasitologic und Therapie tropischer Wurminfektionen. Immun u Infekt 8: 64–74

    CAS  Google Scholar 

  5. Gsell O (1980) Importierte Infektionskrankheiten, Epidemiologie und Therapie. Thieme, Stuttgart

    Google Scholar 

  6. Moreno SNJ, Mason RP, Muniz RPA, Cruz FS, Docampo R (1983) Generation of free radicals from metronidazole and other nitroimidazoles by trichomonas foetus. J Biol Chem 258: 4051–4054

    PubMed  CAS  Google Scholar 

  7. Lossick JG (1982) Treatment of trichomonas vaginalis infections. Rev Infect Dis 4: 5801–5818

    Google Scholar 

  8. Pye RJ, Burton JL (1976) Treatment of rosacea by metronidazole. Lancet 1: 1211–1212

    Article  PubMed  CAS  Google Scholar 

  9. Schirner A, Haneke E (1981) Rosacea und Metronidazol. Aktuel Dermatol 7: 27–30

    Google Scholar 

  10. Braun-Falco O, Körting HC (1983) Metronidazoltherapie der Rosazea. Medikament und Indikation. Hautarzt 34: 261–265

    Google Scholar 

  11. Tannenbaum L, Tuffanelli DL (1980) Antimaterial agents, Chloroquine, hydroxychloroquine, and quinacrine. Arch Dermatol 116: 587–591

    Google Scholar 

  12. Ippen H (1971) Die Therapie der Porphyrien. Dtsch Med Wochenschr 96: 1232

    PubMed  CAS  Google Scholar 

  13. Kordac V, Semrädovä M (1974) Treatment of porphyria cutanea tarda with chloroquine. Br J Dermatol 90: 95

    Article  PubMed  CAS  Google Scholar 

  14. Goerz G, Bolsen K, Merk H (1983) Chloroquin-Therapie der Porphyria cutanea tarda (PCT) und Wirkungsprinzip. Hautarzt [Suppl 1] 34: 309–310

    Google Scholar 

  15. Forth W, Henschler D, Rummel W (1983) Allgemeine und spezielle Pharmakologie und Toxikologie. B.I.-Wissenschaftsverlag, Mannheim Wien Zürich

    Google Scholar 

  16. Garrod LP, Lambert HP, O’Grady F (1981) Antibiotic and chemotherapy, 5. Ed. Churchill Livingstone, Edinburgh

    Google Scholar 

  17. Simon C, Stille W (1982) Antibiotika-Therapie in Klinik und Praxis. 5. Aufl. Schattauer, Stuttgart

    Google Scholar 

  18. Goodman LS, Gilman A (eds) (1980) The pharmacological basis of therapeutics. MacMillan, New York, p 1740

    Google Scholar 

  19. Illig L (1979) Positive Nebenwirkungen antibiotischer bzw. antimikrobieller Substanzen in der Therapie. Infection [Suppl 6] 7: 584

    Article  Google Scholar 

  20. Weber K, Schierz G, Wilske B, Preac-Mursic V, Burgdorfer W, Barbour AG (1984) Antibodies against Ixodes damini- and Ixodes ricinus-spirochetes in tick-borne disorders. Arch Dermatol Res 276: 260

    Google Scholar 

  21. Weck de A (ed) (1984) Allergie drug reactions. Handbook exp Pharmacol Vol 69 Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  22. Expertisen (1983) Die Chemotherapie der Tuberkulose. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose. Hamburg

    Google Scholar 

  23. Stendahl O, Molin L, Dahlgren C (1978) Dapsone inhibits neutrophil myeloperoxidase 02- halide mediated cytotoxicity. J Clin Invest 62: 214–220

    Article  PubMed  CAS  Google Scholar 

  24. Fromm E, Wittmann J (1908) Derivative des p-nitrophenols. Ber Dtsch Chem Ges 41: 2264–2273

    Article  CAS  Google Scholar 

  25. Michaelson G, Molin L, Ohman S, Gip L, Linström B, Skogh M, Trolin I (1976) Clofazemine, a new agent for the treatment of pyoderma grangraenosum. Arch Dermatol 112: 344

    Article  Google Scholar 

  26. Sarracent J, Finlay CM (1982) The action of clofazimine on the level of lysosomal enzymes of cultured macrophages. Clin Exp Immunol 48: 261–267

    PubMed  CAS  Google Scholar 

  27. Klokke AH (1983) Antibakterielle Behandlung der erregerreichen Lepra. Hautarzt 34: 203–208

    PubMed  CAS  Google Scholar 

  28. Rieth H (1979) Mykosen und Antimykotika. Pharmazie in unserer Zeit 8: 161

    PubMed  CAS  Google Scholar 

  29. Quadripur S A (198 3) Antimykotische Therapie. Folgen 1 –6. FdM-Tabellen für die Praxis. Fortschr Med 101: 310

    Google Scholar 

  30. Dorn M (1975) Die Fußpilzerkrankung und ihre Behandlung. Therapiewoche 25: 2941

    Google Scholar 

  31. Dittmar W, Grau W, Raether W, Schrinner E, Wagner WH (1981) Mikrobiologische Laboruntersuchungen mit Ciclopiroxolamin. Arzneimittelforsch 31: 1317–1325

    PubMed  CAS  Google Scholar 

  32. Meinhof W (1983) Ketoconazol - Wende in der antimykotischen Therapie? Hautarzt 34: 155–158

    PubMed  CAS  Google Scholar 

  33. Seeliger HPR, Hauck H (Hrsg) (1982) Chemotherapie von Oberflächen-, Organ- und Systemmykosen. Perimed, Erlangen

    Google Scholar 

  34. Dorn M (1983) Systemische antimykotische Therapie. In Braun-Falco O, Burg G (eds) Fortschritte prakt Dermatol Venerol. Springer, Berlin Heidelberg New York Tokyo, Bd X, S 181–186

    Google Scholar 

  35. Nasemann Th (1974) Viruskrankheiten der Haut, der Schleimhaut und des Genitale. Thieme, Stuttgart

    Google Scholar 

  36. zur Hausen H (1983) Papillomviren, die „heimlichen“Krebserreger? Umweltmedizin 4: 63–64

    Google Scholar 

  37. Guinan ME (1982) Therapy for symptomatic genital herpes simplex virus infection: A review. Rev Infect Dis 4: S819–S828

    Article  Google Scholar 

  38. Landthaler M, Haina D, Waidelich W (1983) Behandlung von Zoster, postzosterischen Schmerzen und Herpes simplex recidivans in loco mit Laser-Licht. Fortschr Med 101: 1039–1041

    PubMed  CAS  Google Scholar 

  39. Clercq de E (1982) Selective antiherpes agents. Trends Pharm Sei 3: 492–5

    Google Scholar 

  40. Przybilla B, Balda BR (1980) Allergische Kontaktdermatitis durch Tromantadin. Münch Med Wochenschr 122: 1195

    CAS  Google Scholar 

  41. Peterslund NA, Seyer-Hansen K, Ipsen J, Esmann V, Schonheyder A, Juhl H (1981) Acyclovir in herpes zoster. Lancet 11: 8251, 827–830

    Article  Google Scholar 

  42. Selby PJ, Powles RL, Jameson B (1979) Parenteral acyclovir therapy for herpes virus infections in man. Lancet 11: 8155, 1267–1270

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatologische Klinik und Poliklinik, der Ludwig-Maximilians-Universität, Frauenlobstr. 9-11, D-8000, München 2, Germany

    Prof.Dr. med. Dr. phil. Johannes Ring

  2. Kneipp-Apotheke und Sebastian-Kneipp Zentral-Institut, Kneippstr. 2, D-8939, Bad Wörishofen, Germany

    Dr. rer. nat. Hans Horst Fröhlich

Authors
  1. Prof.Dr. med. Dr. phil. Johannes Ring
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. rer. nat. Hans Horst Fröhlich
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ring, J., Fröhlich, H.H. (1985). Antimikrobielle Chemotherapeutika. In: Wirkstoffe in der dermatologischen Therapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70025-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70025-5_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13769-6

  • Online ISBN: 978-3-642-70025-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation